Switch to:
More From Other Websites
United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : September 29, 2016 Sep 29 2016
United Therapeutics Chilled On M&A Fever Amid Actelion, Bayer Rivalry Sep 28 2016
United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US :... Sep 28 2016
5 Stocks with Exciting Price-to-Book Ratios Sep 28 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K/A, Regulation FD Disclosure Sep 27 2016
Top 5 Pharma stocks by value : September 27, 2016 Sep 27 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure Sep 27 2016
Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential Sep 22 2016
How Analysts See United Therapeutics’ Continued Performance Sep 01 2016
ETF’s with exposure to United Therapeutics Corp. : August 31, 2016 Aug 31 2016
Physician and Payer Relationships to Increase UTHR’s Drug Access Aug 31 2016
United Therapeutics Makes Novel Technologies a Priority Aug 31 2016
United Therapeutics’ Research Efforts Key to Boosting Stock Aug 31 2016
$1 Billion Sales Target in Place for Tyvaso Aug 30 2016
Generic Competition Not a Threat to UTHR’s Remodulin Aug 30 2016
Strong Growth Projected for UTHR’s Hypertension Drugs Aug 30 2016
Why UTHR Trades at Lower Multiples Compared to Its Peers Aug 30 2016
United Therapeutics Hurt By Competitive Pressure Aug 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK